Winsan (Chengdu) Medical Science And Technology Co (SHSE:600767) Change In Receivables : ¥0.00 Mil (TTM As of Mar. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Winsan (Chengdu) Medical Science And Technology Co Change In Receivables?

Winsan (Chengdu) Medical Science And Technology Co's change in receivables for the quarter that ended in Mar. 2023 was ¥0.00 Mil. It means Winsan (Chengdu) Medical Science And Technology Co's Accounts Receivable stayed the same from Dec. 2022 to Mar. 2023 .

Winsan (Chengdu) Medical Science And Technology Co's change in receivables for the fiscal year that ended in Dec. 2022 was ¥-19.24 Mil. It means Winsan (Chengdu) Medical Science And Technology Co's Accounts Receivable increased by ¥19.24 Mil from Dec. 2021 to Dec. 2022 .

Winsan (Chengdu) Medical Science And Technology Co's Accounts Receivable for the quarter that ended in Mar. 2023 was ¥31.98 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Winsan (Chengdu) Medical Science And Technology Co's Days Sales Outstanding for the three months ended in Mar. 2023 was 436.46.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Winsan (Chengdu) Medical Science And Technology Co's liquidation value for the three months ended in Mar. 2023 was ¥-24.57 Mil.

Winsan (Chengdu) Medical Science And Technology Co Change In Receivables Historical Data

The historical data trend for Winsan (Chengdu) Medical Science And Technology Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winsan (Chengdu) Medical Science And Technology Co Change In Receivables Chart

Winsan (Chengdu) Medical Science And Technology Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

-72.98

2.17

-10.78

2.47

-19.24

Winsan (Chengdu) Medical Science And Technology Co Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Winsan (Chengdu) Medical Science And Technology Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.00 Mil.

Winsan (Chengdu) Medical Science And Technology Co (SHSE:600767) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Winsan (Chengdu) Medical Science And Technology Co's Days Sales Outstanding for the quarter that ended in Mar. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	31.975	/	6.685	*	91
=	436.46

2. In Ben Graham's calculation of liquidation value, Winsan (Chengdu) Medical Science And Technology Co's accounts receivable are only considered to be worth 75% of book value:

Winsan (Chengdu) Medical Science And Technology Co's liquidation value for the quarter that ended in Mar. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	31.323	-	83.951	+	0.75 * 31.975	+	0.5 * 8.154
=	-24.57

Winsan (Chengdu) Medical Science And Technology Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Winsan (Chengdu) Medical Science And Technology Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Winsan (Chengdu) Medical Science And Technology Co (SHSE:600767) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Winsan (Chengdu) Medical Science And Technology Co Ltd (SHSE:600767) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 69 Dongfang Road, Unit 1102-1104, Pudong New District, Shanghai, CHN, 200120

Website

http://www.winsan.cn

Winsan (Chengdu) Medical Science And Technology Co Ltd are engaged in technology development, technical consultation, and technical services in the field of public health and regional medical information. The company projects include Lishui Population Health Information PPP project which includes home pension, chronic disease management, remote diagnosis and treatment, medical insurance, and pharmacy services. It covers approximately 33 public health service agencies, 23 public hospitals, 193 township health centers, and 983 health service stations.

Executives

Ma Wei Guo	Director
Hua En Min	senior management
Jiang Hui Fang	senior management
Guan Wen Lian	Director
Luo Yong Jian	Director
Zhou Luo Man	Supervisors
Qian Min Hua	Director
Wu Ai Qun	Supervisors
Liang Yong Xin	Director

Winsan (Chengdu) Medical Science And Technology Co (SHSE:600767) Headlines

No Headlines